Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Drugs & Pharmacology | Investigational New Drugs | Japan Health | Neurology | Pancreas | Study